Tecemotide
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Tecemotide, covering 2015-11-18 to 2018-03-09. Get the full timeline:
Most recent: Clinical Trial Update: Tecemotide (L-BLP25) in Prostate Cancer [Phase 2]